Astrana Health updated its corporate investor presentation for use at conferences, disclosing operational metrics and financial trends through Q1 2026.
Key takeaways
Updated investor presentation attached as Exhibit 99.1, furnished for Regulation FD.
Presentation includes revenue and G&A trends from FY2023 to Q1 2026.
G&A as a percentage of revenue declined from ~9% in FY2023 to ~4% in Q1 2026.